Literature DB >> 16427606

Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes.

Baoying Chen1, Karen S L Lam, Yu Wang, Donghai Wu, Michael C Lam, Jiangang Shen, Laiching Wong, Ruby L C Hoo, Jialiang Zhang, Aimin Xu.   

Abstract

Low plasma levels of adiponectin (hypoadiponectinemia) and elevated circulating concentrations of plasminogen activator inhibitor (PAI)-1 are causally associated with obesity-related insulin resistance and cardiovascular disease. However, the mechanism that mediates the aberrant production of these two adipokines in obesity remains poorly understood. In this study, we investigated the effects of hypoxia and reactive oxygen species (ROS) on production of adiponectin and PAI-1 in 3T3-L1 adipocytes. Quantitative PCR and immunoassays showed that ambient hypoxia markedly suppressed adiponectin mRNA expression and its protein secretion, and increased PAI-1 production in mature adipocytes. Dimethyloxallyl glycine, a stabilizer of hypoxia-inducible factor 1alpha (HIF-1alpha), mimicked the hypoxia-mediated modulations of these two adipokines. Hypoxia caused a modest elevation of ROS in adipocytes. However, ablation of intracellular ROS by antioxidants failed to alleviate hypoxia-induced aberrant production of adiponectin and PAI-1. On the other hand, the antioxidants could reverse hydrogen peroxide (H2O2)-induced dysregulation of adiponectin and PAI-1 production. H2O2 treatment decreased the expression levels of peroxisome proliferator-activated receptor gamma (PPARgamma) and CCAAT/enhancer binding protein (C/EBPalpha), but had no effect on HIF-1alpha, whereas hypoxia stabilized HIF-1alpha and decreased expression of C/EBPalpha, but not PPARgamma. Taken together, these data suggest that hypoxia and ROS decrease adiponectin production and augment PAI-1 expression in adipocytes via distinct signaling pathways. These effects may contribute to hypoadiponectinemia and elevated PAI-1 levels in obesity, type 2 diabetes, and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427606     DOI: 10.1016/j.bbrc.2006.01.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  69 in total

Review 1.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Effect of continuous positive airway pressure therapy on glucose control.

Authors:  Salim Surani; Shyam Subramanian
Journal:  World J Diabetes       Date:  2012-04-15

3.  Adipokine expression in brown and white adipocytes in response to hypoxia.

Authors:  A Wree; A Mayer; S Westphal; A Beilfuss; A Canbay; R R Schick; G Gerken; P Vaupel
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

4.  Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats.

Authors:  Cuiping Fu; Liyan Jiang; Fen Zhu; Zilong Liu; Wenjing Li; Hong Jiang; Hongying Ye; Clete A Kushida; Shanqun Li
Journal:  Sleep Breath       Date:  2015-02-28       Impact factor: 2.816

5.  Diabetes and sleep apnoea: a hidden epidemic?

Authors:  J Wilding
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

6.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 7.  Morphological and inflammatory changes in visceral adipose tissue during obesity.

Authors:  Xavier S Revelo; Helen Luck; Shawn Winer; Daniel A Winer
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

8.  SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  Sleep Med Clin       Date:  2007-06

Review 9.  Regulation of stem cell differentiation in adipose tissue by chronic inflammation.

Authors:  Jianping Ye; Jeffery M Gimble
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-12       Impact factor: 2.557

Review 10.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.